Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Stroke. 2017 May 19;48(7):1818–1826. doi: 10.1161/STROKEAHA.117.016726

Table 1.

Descriptive characteristics of all CHS participants with incident ischemic stroke and populations eligible for survival analysis and recovery analysis

All CHS participants with incident ischemic stroke (N=893) Eligible Survival Analysis Study Population (N=717) Eligible Recovery Analysis Study Populations (N=509)

Characteristics* N (%) or Mean (SD) or Median [IQR]
Age at time of stroke(years) 81.8 (6.4) 81.0 (6.4) 80.2 (6.6)
Sex
 Female 545 (61.0%) 434 (60.5%) 289 (56.8%)
Race
 White 766 (85.7%) 623 (86.9%) 448 (88.0%)
 Black or Other 128 (14.3%) 94 (13.1%) 61 (12.0%)
Education
 No high school completion 273 (30.5%) 214 (29.9%) 160 (31.4%)
 Completed High School 270 (30.2%) 215 (30.0%) 148 (29.1%)
 Any higher education 351 (39.3%) 288 (40.2%) 201 (39.5%)
Smoking
 Never 442 (49.4%) 362 (50.5%) 269 (52.9%)
 Former 386 (43.2%) 304 (42.4%) 209 (41.1%)
 Current 66 (7.4%) 51 (7.1%) 31 (6.1%)
Alcohol Consumption
 None 561 (62.8%) 437 (61.0%) 298 (58.3%)
 ≤ 5 drinks per week 236 (26.4%) 196 (27.3%) 152 (29.9%)
 > 5 drinks per week 97 (10.9%) 84 (11.7%) 59 (11.6%)
Living Arrangements
 Lives alone 252 (28.2%) 195 (27.2%) 119 (23.4%)
 Lives with others 518 (57.9%) 420 (58.6%) 318 (64.5%)
 Unknown 124 (13.9%) 102 (14.2%) 72 (14.2%)
Prior history of CHD 260 (29.1%) 228 (31.8%) 163 (32.0%)
Prior history of heart failure 83 (9.3%) 77 (10.7%) 56 (11.0%)
Atrial Fibrillation
 Diagnosed prior to stroke 207 (23.2%) 152 (21.2%) 100 (19.7%)
 Diagnosed at stroke 68 (7.6%) 49 (6.8%) 34 (6.7%)
Depressive symptoms (CES-D≥12) 169 (18.9%) 140 (19.5%) 100 (19.7%)
Low Cognitive Function (3MSE<80) 130 (14.7%) 112 (15.8%) 83 (16.5%)
Diabetes 287 (32.3%) 233 (32.6%) 178 (35%)
BMI (kg/m2) 26.8 (4.7) 26.7 (4.6) 26.7 (4.6)
Fatal Stroke 73 (8.2%) 60 (8.4%) 36 (7.1%)
Stroke location
 Left hemisphere 383 (42.8%) 296 (41.3%) 216 (42.5%)
 Right hemisphere 337 (37.7%) 271 (37.8%) 187 (36.7%)
 Basilar 108 (12.1%) 93 (13.0%) 61 (12.0%)
 Other or Unknown 66 (7.4%) 57 (8.0%) 45 (8.8%)
Ischemic Stroke Subtype
 Lacunar 116 (13.0%) 102 (14.2%) 75 (14.7%)
 Atherosclerotic 43 (4.8%) 35 (4.9%) 25 (4.9%)
 Cardio-embolic 249 (27.9%) 187 (26.1%) 125 (24.6%)
 Other and unknown 486 (54.4%) 393 (54.8%) 284 (55.8%)
Anti-hypertensive med. Use 579 (64.8%) 469 (65.4%) 331 (65.0%)
Anticoagulant med. Use 48 (5.4%) 41 (5.7%) 27 (5.3%)
Frailty Status
 Not Frail 148 (27.8%) 160 (30.1%) 111 (28.8%)
 Pre-Frail 292 (54.9%) 294 (55.3%) 217 (56.2%)
 Frail 92 (17.3%) 78 (14.7%) 58 (15.0%)
Slow Walking Speed 279 (44.8%) 280 (44.9%) 212 (46.1%)
Low Grip Strength 192 (32.7%) 192 (32.7%) 149 (34.5%)
C Reactive Protein (mg/dL) 3.0 [1.5–6.5] 3.0 [1.5–6.5] 2.9 [1.5–6.7]
Interleukin-6 (pg/mL) 2.9 [1.9–4.3] 2.9 [1.9–4.3] 2.7 [1.7–4.2]
Cystatin C (mg/dL) 1.1 [1.0–1.3] 1.1 [1.0–1.3] 1.1 [1.0–1.4]
Systolic Blood Pressure (mmHg) 144 (24) 144 (24) 144 (25)
Diastolic Blood Pressure (mmHg) 72 (12) 72 (12) 72 (13)
Total Cholesterol (mg/dL) 208 (41) 208 (41) 209 (41)
*

Most recently obtained measurements that occurred prior to stroke.

Measurements obtained from baseline or years 3, 7, 16 were eligible for this study

HHS Vulnerability Disclosure